Comparison of Pharmacokinetics of Two Fenofibrate Tablet Formulations in Healthy Human Subjects
Comparison of Pharmacokinetics of Two Fenofibrate Tablet Formulations in Healthy Human Subjects
About this item
Full title
Author / Creator
Publisher
Bridgewater, NJ: EM Inc USA
Journal title
Language
English
Formats
Publication information
Publisher
Bridgewater, NJ: EM Inc USA
Subjects
More information
Scope and Contents
Contents
AbstractBackgroundFenofibrate is a serum lipid-lowering agent used as an adjunct to diet in patients with hypercholesterolemia and hypertriglyceridemia. The new fenofibrate tablet formulation was developed as a pharmaceutical equivalent to the marketed tablet formulation containing 145 mg. ObjectiveThe objective of this study was to compare the pha...
Alternative Titles
Full title
Comparison of Pharmacokinetics of Two Fenofibrate Tablet Formulations in Healthy Human Subjects
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1539710011
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1539710011
Other Identifiers
ISSN
0149-2918
E-ISSN
1879-114X
DOI
10.1016/j.clinthera.2014.04.017
